Guru Ownership Trend
Guru Analysis for 4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $6.18 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $11.09 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 26.9%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for 4D Molecular Therapeutics, Inc. (FDMT)
Major holders include Renaissance Technologies (RenTech) ($5.38 M), Cliff Asness ($426,183). According to the latest reported data, 2 tracked investment managers collectively hold approximately 624,042 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $11.09 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited FDMT. The total reported sell value was $11.79 M.
Yes, 0 managers opened new positions in FDMT, and 2 increased their existing holdings. The total reported buy value was $698,789.78.